Identified by NGS, PCR or IHC
1 clinical trials · Condition
◉ Watch Identified by NGS, PCR or IHC
| Record | Firm | Date |
|---|---|---|
| Study of Pembrolizumab Following Surgery in Patients With Microsatellite Instability High (MSI-H) Solid Tumors (NCT03832569) | Memorial Sloan Kettering Cancer Center | 2019-02-20 |
Track Identified by NGS, PCR or IHC automatically
Every clearance here is in the API, with alerts when new ones post.